Renal Denervation Systems Market 2021-2026: Size, Share, Trends and Forecast Report
According to the latest report by IMARC Group, titled, “Rental Denervation Systems Market Growth: Global Industry Trends, Share, Size, Opportunity and Forecast 2021-2026″, the global renal denervation systems market exhibited strong growth during 2015-2020 and expects the market to grow at a CAGR of 37.4% during 2021-2026.
Renal denervation (RDN) stands for an interventional procedure that involves passing a catheter into the renal arteries and ablating sympathetic nerves. It reduces renin secretion, stimulates natriuresis, maximizes nerve disruption, and improves renal blood flow. Owing to these benefits, RDN systems are widely used to treat refractory hypertension cases wherein optimal therapy cannot provide relief to the patients.
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Renal Denervation Systems Market Trends
The growing geriatric population who are more vulnerable to refractory hypertension is primarily augmenting the demand for renal denervation systems. Moreover, the rising consumption of tobacco and alcohol, along with the unhealthy dietary patterns of individuals leading to several lifestyle diseases, are also bolstering the need for renal denervation systems. Furthermore, the increasing consumer awareness towards various benefits associated with the RDN system, such as faster recovery rate, increased time efficiency, improved safety, and cost-effectiveness, is further catalyzing the market growth. Additionally, the escalating demand for minimally invasive surgeries supported by the introduction of micro-infusion technology is anticipated to further drive the market for RDN systems.
Request Free Sample Report: https://www.imarcgroup.com/renal-denervation-systems-market/requestsample
Global Renal Denervation Systems Market 2021-2026 Analysis and Segmentation:
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Boston Scientific Group, Kona Medical Inc., Medtronic Plc, Mercator MedSystems, ReCor Medical Inc. (Otsuka Holdings Co. Ltd.), Renal Dynamics, St. Jude Medical Inc. (Abbott) and Terumo Corporat
The report has segmented the market on the basis on region, product type, product, technology, application and end user.
Breakup by Product Type:
Copper-Based
Single Electrode Catheter
Multi Electrode Catheter
RF Generator
Nerve Modifying Agents
Breakup by Product:
Symplicity
Vessix (V2)
EnligHTN
Paradise
Iberis
Others
Breakup by Technology:
Ultrasound Ablation
Radiofrequency Ablation
Microinfusion
Breakup by Application:
Hypertension
Cardiac Disorders
Diabetes
Renal Failure
Others
Breakup by End User:
Diagnostic Centers and Hospitals
Ambulatory Care Centers
Others
Breakup by Region:
North America; (United States, Canada)
Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America: (Brazil, Mexico,Others)
Middle East and Africa
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/renal-denervation-systems-market
If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Key highlights of the report:
Market Performance (2015-2020)
Market Outlook (2021- 2026)
Porter’s Five Forces Analysis
Market Drivers and Success Factors
SWOT Analysis
Value Chain
Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: [email protected]
Tel No:(D) +91 120 433 0800Veterinary Diagnostics Market:
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800